Anti-inflammatory drugs are the drugs that are used to treat conditions like Asthma, Arthritis, Chronic obstructive pulmonary disease (COPD) and other diseases. Increasing prevalence of these diseases is the major factor propelling the market upwards. Although documented incidences of side effects and patent expiration of Blockbuster drugs are restraining the market growth, new research advancements in Anti Inflammatory Biologics, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs), etc. are helping to make this class of drugs as side effect free as possible, maintaining the efficacy and potency of the drug.
Moreover, increasing awareness of anti-inflammatory therapeutics and attractive government initiatives are expected to drive the overall market.
Key Market Trends
Anti Inflammatory Drugs for Arthritis Treatment is Found Dominating the Market
Arthritis is the inflammation in the joints. There are different types of arthritis, osteoarthritis and rheumatoid arthritis being most common among them. Arthritis is found to be more prevalent in the geriatric population, but there have been some documented cases of arthritis in children as well. Other common forms of arthritis include psoriatic arthritis, fibromyalgia and gout.
Osteoarthritis is caused due to the breakdown of protective cartilage, causing pain and movement of joints difficult. Non-steroidal Anti-Inflammatory drugs (NSAIDs) like diclofenac, ibuprofen and naproxen have been proven to be very effective in suppressing the pain from Osteoarthritis but may cause side effects like stomach upset, cardiovascular problems, bleeding problems, and liver and kidney damage. NSAID gels have also been proven to alleviate the pain and have lesser side effects. Doctors have been turning towards prescribing newest form of Anti-Inflammation drugs called Biologics.
The risk of arthritis has only increased in recent times due to an increase in the sedentary lifestyle, obesity, and unhealthy food habits. Hence, the drug market for its treatment will only see growth in recent future.
North America is Expected to Dominate the Anti-Inflammatory Drugs Market
North America is the largest market in the Anti-Inflammatory Drugs Market due to the factors such as established healthcare sector with a large number of renowned players, high investment & demand for more effective and safer drugs, etc. Moreover, the high income per capita, rise in patient visits to physicians, research advancements due to high funding are some of the factors that are driving the growth of the North American market.
However, Asia Pacific is expected to emerge as the fastest market, driven by a vast patient pool, increasing disposable incomes, growth in healthcare spending, and rising awareness about health.
Competitive Landscape
Majority of the Anti-Inflammatory drugs are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market.
Reasons to Purchase this report:
Moreover, increasing awareness of anti-inflammatory therapeutics and attractive government initiatives are expected to drive the overall market.
Key Market Trends
Anti Inflammatory Drugs for Arthritis Treatment is Found Dominating the Market
Arthritis is the inflammation in the joints. There are different types of arthritis, osteoarthritis and rheumatoid arthritis being most common among them. Arthritis is found to be more prevalent in the geriatric population, but there have been some documented cases of arthritis in children as well. Other common forms of arthritis include psoriatic arthritis, fibromyalgia and gout.
Osteoarthritis is caused due to the breakdown of protective cartilage, causing pain and movement of joints difficult. Non-steroidal Anti-Inflammatory drugs (NSAIDs) like diclofenac, ibuprofen and naproxen have been proven to be very effective in suppressing the pain from Osteoarthritis but may cause side effects like stomach upset, cardiovascular problems, bleeding problems, and liver and kidney damage. NSAID gels have also been proven to alleviate the pain and have lesser side effects. Doctors have been turning towards prescribing newest form of Anti-Inflammation drugs called Biologics.
The risk of arthritis has only increased in recent times due to an increase in the sedentary lifestyle, obesity, and unhealthy food habits. Hence, the drug market for its treatment will only see growth in recent future.
North America is Expected to Dominate the Anti-Inflammatory Drugs Market
North America is the largest market in the Anti-Inflammatory Drugs Market due to the factors such as established healthcare sector with a large number of renowned players, high investment & demand for more effective and safer drugs, etc. Moreover, the high income per capita, rise in patient visits to physicians, research advancements due to high funding are some of the factors that are driving the growth of the North American market.
However, Asia Pacific is expected to emerge as the fastest market, driven by a vast patient pool, increasing disposable incomes, growth in healthcare spending, and rising awareness about health.
Competitive Landscape
Majority of the Anti-Inflammatory drugs are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Pfizer Inc.
- Amgen Inc.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Novartis AG
- F. Hoffmann-La Roche AG
- AbbVie Inc
- AstraZeneca PLC
- Merck & Company, Inc.
- Eli Lily and Company
Methodology
LOADING...
